Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, oncology equipment maker Varian Medical Systems (NYSE: VAR ) has earned a respected four-star ranking.
With that in mind, let's take a closer look at Varian and see what CAPS investors are saying about the stock right now.
Varian facts
|
Headquarters (founded)
|
Palo Alto, Calif. (1948)
|
|
Market Cap
|
$7.8 billion
|
|
Industry
|
Health care equipment
|
|
Trailing-12-Month Revenue
|
$2.9 billion
|
|
Management
|
CEO Dow Wilson (since 2012)
CFO Elisha Finney (since 1999)
|
|
Return on Equity (average, past 3 years)
|
28.4%
|
|
Cash / Debt
|
$807.3 million / $206.3 million
|
|
Competitors
|
Accuray
Elekta
Siemens
|
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 96% of the 404 members who have rated Varian believe the stock will outperform the S&P 500 going forward.
Just yesterday, one of those Fools, dreamjob, succinctly summed up the bull case for our community: "Varian is sporting high returns on capital, and its earnings appear to be quality in nature (operating cash flow is keeping pace with net income). I like how sales, earnings, and book value are growing, and I think I'm getting this for a fair price at $71."
If you want market-topping returns, you need to put together the best portfolio you can. Of course, despite its four-star rating, Varian may not be your top choice.
We've found another growth play we are incredibly excited about -- excited enough to dub it "The Only Stock You Need to Profit from the NEW Technology Revolution." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
RSS Headlines
Fool UK